{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:29:51Z","timestamp":1788557391344,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s40123-022-00482-2","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T09:02:46Z","timestamp":1646211766000},"page":"869-879","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia Treatment"],"prefix":"10.1007","volume":"11","author":[{"given":"Mitchell A.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Giyanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumna","family":"Shabaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Penzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha V.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"George O.","family":"Waring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"issue":"1","key":"482_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1542-0124(12)70120-9","volume":"3","author":"PA Asbell","year":"2005","unstructured":"Asbell PA, Potapova N. Effects of topical antiglaucoma medications on the ocular surface. Ocul Surf. 2005;3(1):27\u201340.","journal-title":"Ocul Surf"},{"issue":"2","key":"482_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","volume":"2","author":"A Patel","year":"2013","unstructured":"Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: an overview. World J Pharmacol. 2013;2(2):47\u201364.","journal-title":"World J Pharmacol"},{"key":"482_CR3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2147\/OPTH.S44708","volume":"8","author":"K Inoue","year":"2014","unstructured":"Inoue K. Managing adverse effects of glaucoma medications. Clin Ophthalmol (Auckland, NZ). 2014;8:903\u201313.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"5","key":"482_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4103\/0253-7613.44151","volume":"40","author":"SK Gupta","year":"2008","unstructured":"Gupta SK, Niranjan DG, Agrawal SS, Srivastava S, Saxena R. Recent advances in pharmacotherapy of glaucoma. Indian J Pharmacol. 2008;40(5):197\u2013208.","journal-title":"Indian J Pharmacol"},{"issue":"2","key":"482_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0002-9394(14)76701-7","volume":"112","author":"PD Drummond","year":"1991","unstructured":"Drummond PD. The effect of light intensity and dose of dilute pilocarpine eyedrops on pupillary constriction in healthy subjects. Am J Ophthalmol. 1991;112(2):195\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"482_CR6","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1001\/jamaophthalmol.2016.1881","volume":"134","author":"A Skaat","year":"2016","unstructured":"Skaat A, Rosman MS, Chien JL, Mogil RS, Ren R, Liebmann JM, et al. Effect of pilocarpine hydrochloride on the Schlemm canal in healthy eyes and eyes with open-angle glaucoma. JAMA Ophthalmol. 2016;134(9):976\u201381.","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"482_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5694\/mja2.50020","volume":"210","author":"J Lusthaus","year":"2019","unstructured":"Lusthaus J, Goldberg I. Current management of glaucoma. Med J Austral. 2019;210(4):180\u20137.","journal-title":"Med J Austral"},{"key":"482_CR8","first-page":"203","volume-title":"A comparison of the ocular hypotensive efficacy, safety and acceptability of brimonidine 0.2% twice daily versus pilocarpine 2.0% thrice daily as adjunct therapy with beta-blockers. In: Glauoma update VI","author":"S Nagasubramanian","year":"2000","unstructured":"Nagasubramanian S. A comparison of the ocular hypotensive efficacy, safety and acceptability of brimonidine 0.2% twice daily versus pilocarpine 2.0% thrice daily as adjunct therapy with beta-blockers. In: Glauoma update VI. Berlin: Springer; 2000. p. 203\u20138."},{"issue":"5","key":"482_CR9","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/eye.2011.82","volume":"25","author":"E Lavik","year":"2011","unstructured":"Lavik E, Kuehn MH, Kwon YH. Novel drug delivery systems for glaucoma. Eye. 2011;25(5):578\u201386.","journal-title":"Eye"},{"issue":"8","key":"482_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/bjo.52.8.607","volume":"52","author":"RA Anderson","year":"1968","unstructured":"Anderson RA, Cowle JB. Influence of pH on the effect of pilocarpine on aqueous dynamics. Br J Ophthalmol. 1968;52(8):607\u201311.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"482_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/jps.2600770911","volume":"77","author":"AK Mitra","year":"1988","unstructured":"Mitra AK, Mikkelson TJ. Mechanism of transcorneal permeation of pilocarpine. J Pharmaceutical Sci. 1988;77(9):771\u20135.","journal-title":"J Pharmaceutical Sci"},{"issue":"8","key":"482_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/bjo.60.8.568","volume":"60","author":"AT Birmingham","year":"1976","unstructured":"Birmingham AT, Galloway NR, Spencer SA. A comparison of the pupilloconstrictor effect of pilocarpine solution administered to the conjunctival sac as a single drop or as a continuous infusion in normal subjects. Br J Ophthalmol. 1976;60(8):568\u201372.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"482_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0002-9394(78)90006-5","volume":"86","author":"WP Boger 3rd","year":"1978","unstructured":"Boger WP 3rd, Steinert RF, Puliafito CA, Pavan-Langston D. Clinical trial comparing timolol ophthalmic solution to pilocarpine in open-angle glaucoma. Am J Ophthalmol. 1978;86(1):8\u201318.","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"482_CR14","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/S0149-2918(00)80008-9","volume":"21","author":"D Hartenbaum","year":"1999","unstructured":"Hartenbaum D, Maloney S, Vaccarelli L, Liss C, Wilson H, Gormley GJ. Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension. Clin Ther. 1999;21(9):1533\u20138.","journal-title":"Clin Ther"},{"issue":"8","key":"482_CR15","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1755-3768.2008.01324.x","volume":"86","author":"J Kaluzny","year":"2008","unstructured":"Kaluzny J, Sobecki R, Czechowicz-Janicka K, Kecik D, Kaluzny BJ, Stewart JA, et al. Efficacy and safety of latanoprost versus pilocarpine\/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension. Acta Ophthalmol. 2008;86(8):860\u20135.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"482_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0149-2918(96)80042-7","volume":"18","author":"R Laibovitz","year":"1996","unstructured":"Laibovitz R, Boyle J, Snyder E, Strohmaier K, Adamsons I. Dorzolamide versus pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily life. Clin Ther. 1996;18(5):821\u201332.","journal-title":"Clin Ther"},{"issue":"1","key":"482_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0021-5155(02)00628-7","volume":"47","author":"M Ozdemir","year":"2003","unstructured":"Ozdemir M, Ozdemir G. Comparison of the intraocular pressure lowering effect of latanoprost and carteolol-pilocarpine combination in newly diagnosed glaucoma. Jpn J Ophthalmol. 2003;47(1):72\u20136.","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"482_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/00061198-199510000-00002","volume":"4","author":"R Laibovitz","year":"1995","unstructured":"Laibovitz R, Strahlman ER, Barber BL, Strohmaier KM. Comparison of quality of life and patient preference of dorzolamide and pilocarpine as adjunctive therapy to timolol in the treatment of glaucoma. J Glaucoma. 1995;4(5):306\u201313.","journal-title":"J Glaucoma"},{"issue":"8","key":"482_CR19","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0161-6420(96)30509-5","volume":"103","author":"ER Strahlman","year":"1996","unstructured":"Strahlman ER, Vogel R, Tipping R, Clineschmidt CM. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group. Ophthalmology. 1996;103(8):1283\u201393.","journal-title":"Ophthalmology"},{"issue":"6","key":"482_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/aos.12308","volume":"92","author":"AD Goertz","year":"2014","unstructured":"Goertz AD, Stewart WC, Burns WR, Stewart JA, Nelson LA. Review of the impact of presbyopia on quality of life in the developing and developed world. Acta Ophthalmol. 2014;92(6):497\u2013500.","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"482_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1475-1313.2007.00484.x","volume":"27","author":"H Radhakrishnan","year":"2007","unstructured":"Radhakrishnan H, Charman WN. Age-related changes in static accommodation and accommodative miosis. Ophthalmic Physiol Opt. 2007;27(4):342\u201352.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"10","key":"482_CR22","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.ophtha.2018.04.013","volume":"125","author":"TR Fricke","year":"2018","unstructured":"Fricke TR, Tahhan N, Resnikoff S, Papas E, Burnett A, Ho SM, et al. Global prevalence of presbyopia and vision impairment from uncorrected presbyopia: systematic review, meta-analysis, and modelling. Ophthalmology. 2018;125(10):1492\u20139.","journal-title":"Ophthalmology"},{"key":"482_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.preteyeres.2018.09.004","volume":"68","author":"JS Wolffsohn","year":"2019","unstructured":"Wolffsohn JS, Davies LN. Presbyopia: effectiveness of correction strategies. Prog Retin Eye Res. 2019;68:124\u201343.","journal-title":"Prog Retin Eye Res"},{"key":"482_CR24","unstructured":"Stokes J, Shirneshan E, Graham CA, Paulich M, Johnson N. Exploring the experience of living with and treating presbyopia. Virtual poster presented at: American Academy of Optometry Annual Meeting 2020; October 7, 2020. https:\/\/www.aaopt.org\/detail\/knowledge-base-article\/psychometric-evaluation-of-the-near-vision-presbyopia-taskbased-questionnaire-using-phase-2b-clinical-trial-data. Accessed 24 Feb 2022."},{"issue":"3","key":"482_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.14227\/DT180311P15","volume":"18","author":"MRC Marques","year":"2011","unstructured":"Marques MRC, Loebenberg R, Almukainzi M. Simulated biological fluids with possible application in dissolution testing. Dissolut Technol. 2011;18(3):15\u201328.","journal-title":"Dissolut Technol"},{"issue":"1","key":"482_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/pharmaceutics4010243","volume":"4","author":"I Januleviciene","year":"2012","unstructured":"Januleviciene I, Siaudvytyte L, Barsauskaite R. Ophthalmic drug delivery in glaucoma\u2014a review. Pharmaceutics. 2012;4(1):243\u201351.","journal-title":"Pharmaceutics"},{"issue":"1","key":"482_CR27","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1080\/10717544.2020.1775726","volume":"27","author":"N Jain","year":"2020","unstructured":"Jain N, Verma A, Jain N. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits. Drug Deliv. 2020;27(1):888\u201399.","journal-title":"Drug Deliv"},{"issue":"2","key":"482_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40123-019-0180-z","volume":"8","author":"K Shinno","year":"2019","unstructured":"Shinno K, Kurokawa K, Kozai S, Kawamura A, Inada K, Tokushige H. Effect of solution pH on distribution of ophthalmically administered brimonidine in posterior ocular tissues in pigmented rabbits. Ophthalmol Ther. 2019;8(2):271\u20137.","journal-title":"Ophthalmol Ther"},{"key":"482_CR29","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.2147\/OPTH.S211584","volume":"13","author":"L Gouvea","year":"2019","unstructured":"Gouvea L, Waring GO, Brundrett A, Crouse M, Rocha KM. Objective assessment of optical quality in dry eye disease using a double-pass imaging system. Clin Ophthalmol (Auckland, NZ). 2019;13:1991\u20136.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"12","key":"482_CR30","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1136\/bjophthalmol-2018-312333","volume":"102","author":"S Koh","year":"2018","unstructured":"Koh S, Tung CI, Inoue Y, Jhanji V. Effects of tear film dynamics on quality of vision. Br J Ophthalmol. 2018;102(12):1615.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"482_CR31","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1167\/iovs.15-18985","volume":"57","author":"A-Y Yu","year":"2016","unstructured":"Yu A-Y, Lu T, Pan A-P, Lin D-R, Xu C-C, Huang J-H, et al. Assessment of tear film optical quality dynamics. Invest Ophthalmol Vis Sci. 2016;57(8):3821\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"482_CR32","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.jcrs.2007.06.019","volume":"33","author":"R Mont\u00e9s-Mic\u00f3","year":"2007","unstructured":"Mont\u00e9s-Mic\u00f3 R. Role of the tear film in the optical quality of the human eye. J Cataract Refract Surg. 2007;33(9):1631\u20135.","journal-title":"J Cataract Refract Surg"},{"issue":"7","key":"482_CR33","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1167\/iovs.13-12409","volume":"54","author":"S Koh","year":"2013","unstructured":"Koh S, Maeda N, Ikeda C, Takai Y, Fujimoto H, Oie Y, et al. Effect of instillation of eyedrops for dry eye on optical quality. Invest Ophthalmol Vis Sci. 2013;54(7):4927\u201333.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"482_CR34","first-page":"1342056","volume":"2016","author":"N Lu","year":"2016","unstructured":"Lu N, Lin F, Huang Z, He Q, Han W. Changes of corneal wavefront aberrations in dry eye patients after treatment with artificial lubricant drops. J Ophthalmol. 2016;2016:1342056.","journal-title":"J Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-022-00482-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-022-00482-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-022-00482-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T16:47:22Z","timestamp":1647449242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-022-00482-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1007\/s40123-022-00482-2","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]},"assertion":[{"value":"4 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}